Viewing Study NCT00076856


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-10 @ 2:17 PM
Study NCT ID: NCT00076856
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2004-02-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
None Neoplasm Metastasis View
None Brain Neoplasms View
Keywords: